The global market for Connected Injectable Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Connected Injectable Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Connected Injectable Drug Delivery Devices.

The Connected Injectable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Connected Injectable Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Connected Injectable Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Connected Injectable Drug Delivery Devices Market Report

Report Metric	Details
Report Name	Connected Injectable Drug Delivery Devices Market
CAGR	5%
Segment by Type	Conventional Injection Devices Self-Injection Devices Others
Segment by Application	Diabetes Cardiovascular Diseases Autoimmune Diseases Hormones Replacement Neurology Addiction Respiratory Diseases Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Phillips-Medisize, West Pharmaceutical Services, Biocorp, Aterica, Unilife, Propeller Health, Haselmeier, SHL, Becton Dickinson, Baxter International, Scandinavian Health, Ypsomed, Terumo Medical, Schott, Owen Mumford, Antares Pharma, Zogenix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Connected Injectable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Connected Injectable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Connected Injectable Drug Delivery Devices Market report?

Ans: The main players in the Connected Injectable Drug Delivery Devices Market are Phillips-Medisize, West Pharmaceutical Services, Biocorp, Aterica, Unilife, Propeller Health, Haselmeier, SHL, Becton Dickinson, Baxter International, Scandinavian Health, Ypsomed, Terumo Medical, Schott, Owen Mumford, Antares Pharma, Zogenix

What are the Application segmentation covered in the Connected Injectable Drug Delivery Devices Market report?

Ans: The Applications covered in the Connected Injectable Drug Delivery Devices Market report are Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Hormones Replacement, Neurology, Addiction, Respiratory Diseases, Others

What are the Type segmentation covered in the Connected Injectable Drug Delivery Devices Market report?

Ans: The Types covered in the Connected Injectable Drug Delivery Devices Market report are Conventional Injection Devices, Self-Injection Devices, Others

1 Connected Injectable Drug Delivery Devices Market Overview

1.1 Product Definition

1.2 Connected Injectable Drug Delivery Devices by Type

1.2.1 Global Connected Injectable Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Conventional Injection Devices

1.2.3 Self-Injection Devices

1.2.4 Others

1.3 Connected Injectable Drug Delivery Devices by Application

1.3.1 Global Connected Injectable Drug Delivery Devices Market Value by Application (2024 VS 2031)

1.3.2 Diabetes

1.3.3 Cardiovascular Diseases

1.3.4 Autoimmune Diseases

1.3.5 Hormones Replacement

1.3.6 Neurology

1.3.7 Addiction

1.3.8 Respiratory Diseases

1.3.9 Others

1.4 Global Connected Injectable Drug Delivery Devices Market Size Estimates and Forecasts

1.4.1 Global Connected Injectable Drug Delivery Devices Revenue 2020-2031

1.4.2 Global Connected Injectable Drug Delivery Devices Sales 2020-2031

1.4.3 Global Connected Injectable Drug Delivery Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Connected Injectable Drug Delivery Devices Market Competition by Manufacturers

2.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Connected Injectable Drug Delivery Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Connected Injectable Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Product Type & Application

2.7 Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Date of Enter into This Industry

2.8 Global Connected Injectable Drug Delivery Devices Market Competitive Situation and Trends

2.8.1 Global Connected Injectable Drug Delivery Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Connected Injectable Drug Delivery Devices Players Market Share by Revenue

2.8.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Connected Injectable Drug Delivery Devices Market Scenario by Region

3.1 Global Connected Injectable Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Connected Injectable Drug Delivery Devices Sales by Region: 2020-2031

3.2.1 Global Connected Injectable Drug Delivery Devices Sales by Region: 2020-2025

3.2.2 Global Connected Injectable Drug Delivery Devices Sales by Region: 2026-2031

3.3 Global Connected Injectable Drug Delivery Devices Revenue by Region: 2020-2031

3.3.1 Global Connected Injectable Drug Delivery Devices Revenue by Region: 2020-2025

3.3.2 Global Connected Injectable Drug Delivery Devices Revenue by Region: 2026-2031

3.4 North America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country

3.4.1 North America Connected Injectable Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Connected Injectable Drug Delivery Devices Sales by Country (2020-2031)

3.4.3 North America Connected Injectable Drug Delivery Devices Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures by Country

3.5.1 Europe Connected Injectable Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Connected Injectable Drug Delivery Devices Sales by Country (2020-2031)

3.5.3 Europe Connected Injectable Drug Delivery Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Connected Injectable Drug Delivery Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Connected Injectable Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country

3.7.1 Latin America Connected Injectable Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Connected Injectable Drug Delivery Devices Sales by Country (2020-2031)

3.7.3 Latin America Connected Injectable Drug Delivery Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Connected Injectable Drug Delivery Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Connected Injectable Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Connected Injectable Drug Delivery Devices Sales by Type (2020-2031)

4.1.1 Global Connected Injectable Drug Delivery Devices Sales by Type (2020-2025)

4.1.2 Global Connected Injectable Drug Delivery Devices Sales by Type (2026-2031)

4.1.3 Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2020-2031)

4.2 Global Connected Injectable Drug Delivery Devices Revenue by Type (2020-2031)

4.2.1 Global Connected Injectable Drug Delivery Devices Revenue by Type (2020-2025)

4.2.2 Global Connected Injectable Drug Delivery Devices Revenue by Type (2026-2031)

4.2.3 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2020-2031)

4.3 Global Connected Injectable Drug Delivery Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Connected Injectable Drug Delivery Devices Sales by Application (2020-2031)

5.1.1 Global Connected Injectable Drug Delivery Devices Sales by Application (2020-2025)

5.1.2 Global Connected Injectable Drug Delivery Devices Sales by Application (2026-2031)

5.1.3 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2020-2031)

5.2 Global Connected Injectable Drug Delivery Devices Revenue by Application (2020-2031)

5.2.1 Global Connected Injectable Drug Delivery Devices Revenue by Application (2020-2025)

5.2.2 Global Connected Injectable Drug Delivery Devices Revenue by Application (2026-2031)

5.2.3 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2020-2031)

5.3 Global Connected Injectable Drug Delivery Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Phillips-Medisize

6.1.1 Phillips-Medisize Company Information

6.1.2 Phillips-Medisize Description and Business Overview

6.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Product Portfolio

6.1.5 Phillips-Medisize Recent Developments/Updates

6.2 West Pharmaceutical Services

6.2.1 West Pharmaceutical Services Company Information

6.2.2 West Pharmaceutical Services Description and Business Overview

6.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product Portfolio

6.2.5 West Pharmaceutical Services Recent Developments/Updates

6.3 Biocorp

6.3.1 Biocorp Company Information

6.3.2 Biocorp Description and Business Overview

6.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Biocorp Connected Injectable Drug Delivery Devices Product Portfolio

6.3.5 Biocorp Recent Developments/Updates

6.4 Aterica

6.4.1 Aterica Company Information

6.4.2 Aterica Description and Business Overview

6.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Aterica Connected Injectable Drug Delivery Devices Product Portfolio

6.4.5 Aterica Recent Developments/Updates

6.5 Unilife

6.5.1 Unilife Company Information

6.5.2 Unilife Description and Business Overview

6.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Unilife Connected Injectable Drug Delivery Devices Product Portfolio

6.5.5 Unilife Recent Developments/Updates

6.6 Propeller Health

6.6.1 Propeller Health Company Information

6.6.2 Propeller Health Description and Business Overview

6.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Propeller Health Connected Injectable Drug Delivery Devices Product Portfolio

6.6.5 Propeller Health Recent Developments/Updates

6.7 Haselmeier

6.7.1 Haselmeier Company Information

6.7.2 Haselmeier Description and Business Overview

6.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Haselmeier Connected Injectable Drug Delivery Devices Product Portfolio

6.7.5 Haselmeier Recent Developments/Updates

6.8 SHL

6.8.1 SHL Company Information

6.8.2 SHL Description and Business Overview

6.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 SHL Connected Injectable Drug Delivery Devices Product Portfolio

6.8.5 SHL Recent Developments/Updates

6.9 Becton Dickinson

6.9.1 Becton Dickinson Company Information

6.9.2 Becton Dickinson Description and Business Overview

6.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Product Portfolio

6.9.5 Becton Dickinson Recent Developments/Updates

6.10 Baxter International

6.10.1 Baxter International Company Information

6.10.2 Baxter International Description and Business Overview

6.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Baxter International Connected Injectable Drug Delivery Devices Product Portfolio

6.10.5 Baxter International Recent Developments/Updates

6.11 Scandinavian Health

6.11.1 Scandinavian Health Company Information

6.11.2 Scandinavian Health Description and Business Overview

6.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Product Portfolio

6.11.5 Scandinavian Health Recent Developments/Updates

6.12 Ypsomed

6.12.1 Ypsomed Company Information

6.12.2 Ypsomed Description and Business Overview

6.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Ypsomed Connected Injectable Drug Delivery Devices Product Portfolio

6.12.5 Ypsomed Recent Developments/Updates

6.13 Terumo Medical

6.13.1 Terumo Medical Company Information

6.13.2 Terumo Medical Description and Business Overview

6.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Terumo Medical Connected Injectable Drug Delivery Devices Product Portfolio

6.13.5 Terumo Medical Recent Developments/Updates

6.14 Schott

6.14.1 Schott Company Information

6.14.2 Schott Description and Business Overview

6.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Schott Connected Injectable Drug Delivery Devices Product Portfolio

6.14.5 Schott Recent Developments/Updates

6.15 Owen Mumford

6.15.1 Owen Mumford Company Information

6.15.2 Owen Mumford Description and Business Overview

6.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Owen Mumford Connected Injectable Drug Delivery Devices Product Portfolio

6.15.5 Owen Mumford Recent Developments/Updates

6.16 Antares Pharma

6.16.1 Antares Pharma Company Information

6.16.2 Antares Pharma Description and Business Overview

6.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Antares Pharma Connected Injectable Drug Delivery Devices Product Portfolio

6.16.5 Antares Pharma Recent Developments/Updates

6.17 Zogenix

6.17.1 Zogenix Company Information

6.17.2 Zogenix Description and Business Overview

6.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Zogenix Connected Injectable Drug Delivery Devices Product Portfolio

6.17.5 Zogenix Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Connected Injectable Drug Delivery Devices Industry Chain Analysis

7.2 Connected Injectable Drug Delivery Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Connected Injectable Drug Delivery Devices Production Mode & Process Analysis

7.4 Connected Injectable Drug Delivery Devices Sales and Marketing

7.4.1 Connected Injectable Drug Delivery Devices Sales Channels

7.4.2 Connected Injectable Drug Delivery Devices Distributors

7.5 Connected Injectable Drug Delivery Devices Customer Analysis

8 Connected Injectable Drug Delivery Devices Market Dynamics

8.1 Connected Injectable Drug Delivery Devices Industry Trends

8.2 Connected Injectable Drug Delivery Devices Market Drivers

8.3 Connected Injectable Drug Delivery Devices Market Challenges

8.4 Connected Injectable Drug Delivery Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Phillips-Medisize

West Pharmaceutical Services

List of Tables

Table 1. Global Connected Injectable Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Connected Injectable Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Connected Injectable Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Connected Injectable Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Connected Injectable Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Connected Injectable Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Product Type & Application

Table 12. Global Key Manufacturers of Connected Injectable Drug Delivery Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Connected Injectable Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Connected Injectable Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Connected Injectable Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 18. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2020-2025)

Table 19. Global Connected Injectable Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 20. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2026-2031)

Table 21. Global Connected Injectable Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Connected Injectable Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Connected Injectable Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Connected Injectable Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 27. North America Connected Injectable Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 28. North America Connected Injectable Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Connected Injectable Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Connected Injectable Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Connected Injectable Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 32. Europe Connected Injectable Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 33. Europe Connected Injectable Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Connected Injectable Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Connected Injectable Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Connected Injectable Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Connected Injectable Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Connected Injectable Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Connected Injectable Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Type (2020-2025)

Table 51. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Type (2026-2031)

Table 52. Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2020-2025)

Table 53. Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2026-2031)

Table 54. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Type (2020-2025)

Table 59. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Type (2026-2031)

Table 60. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Application (2020-2025)

Table 61. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Application (2026-2031)

Table 62. Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2020-2025)

Table 63. Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2026-2031)

Table 64. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Application (2020-2025)

Table 69. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Application (2026-2031)

Table 70. Phillips-Medisize Company Information

Table 71. Phillips-Medisize Description and Business Overview

Table 72. Phillips-Medisize Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Phillips-Medisize Connected Injectable Drug Delivery Devices Product

Table 74. Phillips-Medisize Recent Developments/Updates

Table 75. West Pharmaceutical Services Company Information

Table 76. West Pharmaceutical Services Description and Business Overview

Table 77. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product

Table 79. West Pharmaceutical Services Recent Developments/Updates

Table 80. Biocorp Company Information

Table 81. Biocorp Description and Business Overview

Table 82. Biocorp Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Biocorp Connected Injectable Drug Delivery Devices Product

Table 84. Biocorp Recent Developments/Updates

Table 85. Aterica Company Information

Table 86. Aterica Description and Business Overview

Table 87. Aterica Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Aterica Connected Injectable Drug Delivery Devices Product

Table 89. Aterica Recent Developments/Updates

Table 90. Unilife Company Information

Table 91. Unilife Description and Business Overview

Table 92. Unilife Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Unilife Connected Injectable Drug Delivery Devices Product

Table 94. Unilife Recent Developments/Updates

Table 95. Propeller Health Company Information

Table 96. Propeller Health Description and Business Overview

Table 97. Propeller Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Propeller Health Connected Injectable Drug Delivery Devices Product

Table 99. Propeller Health Recent Developments/Updates

Table 100. Haselmeier Company Information

Table 101. Haselmeier Description and Business Overview

Table 102. Haselmeier Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Haselmeier Connected Injectable Drug Delivery Devices Product

Table 104. Haselmeier Recent Developments/Updates

Table 105. SHL Company Information

Table 106. SHL Description and Business Overview

Table 107. SHL Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. SHL Connected Injectable Drug Delivery Devices Product

Table 109. SHL Recent Developments/Updates

Table 110. Becton Dickinson Company Information

Table 111. Becton Dickinson Description and Business Overview

Table 112. Becton Dickinson Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Becton Dickinson Connected Injectable Drug Delivery Devices Product

Table 114. Becton Dickinson Recent Developments/Updates

Table 115. Baxter International Company Information

Table 116. Baxter International Description and Business Overview

Table 117. Baxter International Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Baxter International Connected Injectable Drug Delivery Devices Product

Table 119. Baxter International Recent Developments/Updates

Table 120. Scandinavian Health Company Information

Table 121. Scandinavian Health Description and Business Overview

Table 122. Scandinavian Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Scandinavian Health Connected Injectable Drug Delivery Devices Product

Table 124. Scandinavian Health Recent Developments/Updates

Table 125. Ypsomed Company Information

Table 126. Ypsomed Description and Business Overview

Table 127. Ypsomed Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Ypsomed Connected Injectable Drug Delivery Devices Product

Table 129. Ypsomed Recent Developments/Updates

Table 130. Terumo Medical Company Information

Table 131. Terumo Medical Description and Business Overview

Table 132. Terumo Medical Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Terumo Medical Connected Injectable Drug Delivery Devices Product

Table 134. Terumo Medical Recent Developments/Updates

Table 135. Schott Company Information

Table 136. Schott Description and Business Overview

Table 137. Schott Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Schott Connected Injectable Drug Delivery Devices Product

Table 139. Schott Recent Developments/Updates

Table 140. Owen Mumford Company Information

Table 141. Owen Mumford Description and Business Overview

Table 142. Owen Mumford Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Owen Mumford Connected Injectable Drug Delivery Devices Product

Table 144. Owen Mumford Recent Developments/Updates

Table 145. Antares Pharma Company Information

Table 146. Antares Pharma Description and Business Overview

Table 147. Antares Pharma Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Antares Pharma Connected Injectable Drug Delivery Devices Product

Table 149. Antares Pharma Recent Developments/Updates

Table 150. Zogenix Company Information

Table 151. Zogenix Description and Business Overview

Table 152. Zogenix Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Zogenix Connected Injectable Drug Delivery Devices Product

Table 154. Zogenix Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Connected Injectable Drug Delivery Devices Distributors List

Table 158. Connected Injectable Drug Delivery Devices Customers List

Table 159. Connected Injectable Drug Delivery Devices Market Trends

Table 160. Connected Injectable Drug Delivery Devices Market Drivers

Table 161. Connected Injectable Drug Delivery Devices Market Challenges

Table 162. Connected Injectable Drug Delivery Devices Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Connected Injectable Drug Delivery Devices

Figure 2. Global Connected Injectable Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Connected Injectable Drug Delivery Devices Market Share by Type: 2024 & 2031

Figure 4. Conventional Injection Devices Product Picture

Figure 5. Self-Injection Devices Product Picture

Figure 6. Others Product Picture

Figure 7. Global Connected Injectable Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Connected Injectable Drug Delivery Devices Market Share by Application: 2024 & 2031

Figure 9. Diabetes

Figure 10. Cardiovascular Diseases

Figure 11. Autoimmune Diseases

Figure 12. Hormones Replacement

Figure 13. Neurology

Figure 14. Addiction

Figure 15. Respiratory Diseases

Figure 16. Others

Figure 17. Global Connected Injectable Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Connected Injectable Drug Delivery Devices Market Size (2020-2031) & (US$ Million)

Figure 19. Global Connected Injectable Drug Delivery Devices Sales (2020-2031) & (K Units)

Figure 20. Global Connected Injectable Drug Delivery Devices Average Price (USD/Unit) & (2020-2031)

Figure 21. Connected Injectable Drug Delivery Devices Report Years Considered

Figure 22. Connected Injectable Drug Delivery Devices Sales Share by Manufacturers in 2024

Figure 23. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers in 2024

Figure 24. Global 5 and 10 Largest Connected Injectable Drug Delivery Devices Players: Market Share by Revenue in Connected Injectable Drug Delivery Devices in 2024

Figure 25. Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Global Connected Injectable Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 27. North America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 28. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 29. U.S. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Canada Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Europe Connected Injectable Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 32. Europe Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 33. Germany Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. France Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. U.K. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Italy Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Russia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Asia Pacific Connected Injectable Drug Delivery Devices Sales Market Share by Region (2020-2031)

Figure 39. Asia Pacific Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2020-2031)

Figure 40. China Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Japan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. South Korea Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. India Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Australia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Taiwan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Indonesia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Thailand Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Malaysia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Philippines Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Latin America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 51. Latin America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 52. Mexico Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Brazil Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Argentina Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Middle East and Africa Connected Injectable Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 57. Turkey Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. UAE Connected Injectable Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Global Sales Market Share of Connected Injectable Drug Delivery Devices by Type (2020-2031)

Figure 61. Global Revenue Market Share of Connected Injectable Drug Delivery Devices by Type (2020-2031)

Figure 62. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Type (2020-2031)

Figure 63. Global Sales Market Share of Connected Injectable Drug Delivery Devices by Application (2020-2031)

Figure 64. Global Revenue Market Share of Connected Injectable Drug Delivery Devices by Application (2020-2031)

Figure 65. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Application (2020-2031)

Figure 66. Connected Injectable Drug Delivery Devices Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions